Renqiang Yu | Medicine and Dentistry | Best Researcher Award

Dr. Renqiang Yu | Medicine and Dentistry | Best Researcher Award

Deputy Chief PhysicianĀ  at Affiliated Women’s Hospital of Jiangnan University, China

Dr. Renqiang Yu, born on November 3, 1986, is a distinguished Chinese medical professional specializing in pediatrics and clinical research. He currently serves as a Deputy Chief Physician at the Affiliated Womenā€™s Hospital of Jiangnan University. With a robust academic background, Dr. Yu has contributed significantly to the fields of pulmonary angiogenesis, atopic dermatitis, and neonatal health. His recent research focuses on the role of probiotics and short-chain fatty acids in health and disease prevention. He leads multiple nationally funded projects and has published extensively in high-impact journals, covering topics such as gut health, microbiota, and immune modulation. Dr. Yu’s leadership is recognized through his editorial role at Frontiers in Microbiology as a guest associate editor. His innovative research continues to enhance neonatal care and improve the quality of life for children affected by various conditions, positioning him as a leader in his field.

Professional Profile

Education

Dr. Renqiang Yu earned his Doctor of Medicine (M.D.) degree from Nanjing Medical University, one of Chinaā€™s top medical institutions. His educational journey provided him with a strong foundation in medical sciences, particularly in pediatrics and clinical research. His academic training was marked by a focus on pediatric diseases, neonatology, and immunology, equipping him with the expertise to address critical issues in neonatal health. Dr. Yuā€™s commitment to advancing medical research is reflected in his continuous engagement with the latest scientific advancements, as he integrates cutting-edge knowledge into his clinical practice. This rigorous academic background has played a crucial role in his ability to lead groundbreaking research and medical initiatives that address public health challenges.

Professional Experience

Dr. Renqiang Yu has a notable career in both clinical and research settings. Currently, he is the Deputy Chief Physician at the Affiliated Womenā€™s Hospital of Jiangnan University, where he leads clinical practices focusing on pediatric and neonatal care. In addition to his clinical duties, Dr. Yu plays an instrumental role in shaping medical research, particularly through his leadership in multiple funded projects. He has served as the principal investigator for projects funded by the National Natural Science Foundation of China, exploring topics such as pulmonary angiogenesis and atopic dermatitis. His work has earned recognition from both national and international scientific communities. Dr. Yu’s diverse professional roles, including his editorial position with Frontiers in Microbiology, reflect his broad impact in the medical field, bridging clinical excellence with groundbreaking research initiatives.

Research Interest

Dr. Renqiang Yuā€™s research interests focus primarily on pediatrics, neonatal health, and clinical immunology, with a special emphasis on gut microbiota and its impact on immune function. His work explores the mechanisms of pulmonary angiogenesis, particularly in neonates, and the role of probiotics and short-chain fatty acids in disease prevention and immune regulation. Dr. Yu has also delved into the pathophysiology of atopic dermatitis, investigating novel therapeutic approaches to treat this condition. His research contributes significantly to understanding the gut-skin axis and its implications for pediatric diseases. Furthermore, he is interested in the development of innovative treatments for neonatal illnesses, striving to improve patient outcomes through the application of his findings. Through these endeavors, Dr. Yu seeks to bridge the gap between basic science and clinical applications, paving the way for improved pediatric healthcare practices worldwide.

Awards and Honors

Dr. Renqiang Yu has received numerous prestigious awards and honors throughout his career, reflecting his outstanding contributions to the fields of pediatrics and medical research. He was recognized as a key participant in national research initiatives, securing multiple grants from the National Natural Science Foundation of China for his studies on pediatric diseases and immune system modulation. Dr. Yuā€™s innovative work has earned him recognition from leading academic institutions, and his contributions to advancing neonatal care have been widely acknowledged by his peers. His editorial role in Frontiers in Microbiology further underscores his leadership in the academic community. In addition to these honors, Dr. Yu has been invited to deliver lectures at various international conferences, where he shares his expertise on pediatric immunology and gut health. These accolades affirm his standing as a leading researcher in the field, dedicated to advancing healthcare for children globally.

Publications Top Noted

  • Title: Nrf2 protects against seawater drowning-induced acute lung injury via inhibiting ferroptosis
    Authors: Y Qiu, B Wan, G Liu, Y Wu, D Chen, M Lu, J Chen, R Yu, D Chen, Q Pang
    Journal: Respiratory Research
    Year: 2020
    Citations: 131
  • Title: Inhibition of HMGB1 improves necrotizing enterocolitis by inhibiting NLRP3 via TLR4 and NFā€ĪŗB signaling pathways
    Authors: R Yu, S Jiang, Y Tao, P Li, J Yin, Q Zhou
    Journal: Journal of Cellular Physiology
    Year: 2019
    Citations: 109
  • Title: Fatty acid profile and the sn-2 position distribution in triacylglycerols of breast milk during different lactation stages
    Authors: C Qi, J Sun, Y Xia, R Yu, W Wei, J Xiang, Q Jin, H Xiao, X Wang
    Journal: Journal of Agricultural and Food Chemistry
    Year: 2018
    Citations: 102
  • Title: Maternal vitamin D status in the late second trimester and the risk of severe preeclampsia in Southeastern China
    Authors: X Zhao, R Fang, R Yu, D Chen, J Zhao, J Xiao
    Journal: Nutrients
    Year: 2017
    Citations: 99
  • Title: Modulation of fat metabolism and gut microbiota by resveratrol on high-fat diet-induced obese mice
    Authors: CL Campbell, R Yu, F Li, Q Zhou, D Chen, C Qi, Y Yin, J Sun
    Journal: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
    Year: 2019
    Citations: 79
  • Title: Triacylglycerol composition of breast milk during different lactation stages
    Authors: T Yuan, C Qi, X Dai, Y Xia, C Sun, J Sun, R Yu, Q Zhou, Q Jin, W Wei, …
    Journal: Journal of Agricultural and Food Chemistry
    Year: 2019
    Citations: 68
  • Title: Lactobacillus reuteri improves gut barrier function and affects diurnal variation of the gut microbiota in mice fed a high-fat diet
    Authors: S Li, C Qi, H Zhu, R Yu, C Xie, Y Peng, SW Yin, J Fan, S Zhao, J Sun
    Journal: Food & Function
    Year: 2019
    Citations: 58
  • Title: Evaluating the activity of sodium butyrate to prevent osteoporosis in rats by promoting osteal GSK-3Ī²/Nrf2 signaling and mitochondrial function
    Authors: X Tang, S Ma, Y Li, Y Sun, K Zhang, Q Zhou, R Yu
    Journal: Journal of Agricultural and Food Chemistry
    Year: 2020
    Citations: 46
  • Title: Short-chain fatty acid (SCFA) and medium-chain fatty acid (MCFA) concentrations in human milk consumed by infants born at different gestational ages and the variations in ā€¦
    Authors: X Dai, T Yuan, X Zhang, Q Zhou, H Bi, R Yu, W Wei, X Wang
    Journal: Food & Function
    Year: 2020
    Citations: 44
  • Title: Protective effects of Ī³-aminobutyric acid against H2O2-induced oxidative stress in RIN-m5F pancreatic cells
    Authors: X Tang, R Yu, Q Zhou, S Jiang, G Le
    Journal: Nutrition & Metabolism
    Year: 2018
    Citations: 40

Weifang Liao | Medicine and Dentistry | Best Researcher Award

Dr. Weifang Liao | Medicine and Dentistry | Best Researcher Award

Associate Professor at Jiujiang University Affiliated Hospital, China

Weifang Liao is an Associate Professor at the School of Clinical Medicine, Jiujiang University. With a strong background in medicine and epidemiology, Liao has actively contributed to biomedical research, particularly in wound healing and drug delivery systems. His work integrates traditional Chinese and Western medicine, emphasizing innovative approaches in biomaterials and hydrogel-based therapeutics. He has secured multiple research grants and published extensively in high-impact journals. Liaoā€™s research has been instrumental in advancing regenerative medicine and improving treatment methodologies for complex medical conditions, including diabetic wound healing and colorectal cancer diagnostics.

Professional ProfileĀ 

Education

Weifang Liao earned his Ph.D. in Medicine from Wonkwang University, South Korea, in 2021. He holds a Masterā€™s degree in Epidemiology and Health Statistics from Guizhou Medical University, obtained in 2015. His academic journey began at Jiujiang University, where he studied Integrated Chinese and Western Medicine from 2003 to 2006. His educational background reflects a strong foundation in medical research, public health, and clinical applications, equipping him with interdisciplinary expertise to contribute significantly to the field of biomedical science and healthcare innovation.

Professional Experience

Liao is currently an Associate Professor at Jiujiang Universityā€™s School of Clinical Medicine. Previously, he was a Lecturer at the same institution from 2015 to 2018. He also gained practical medical experience as a Medical Officer at Zhegang Health Center under the Poyang County Health Commission (2008-2012). His postdoctoral research at Wonkwang University (2021-2022) enhanced his expertise in biomaterials and medical technology. Additionally, he has been engaged in academic collaborations with Huazhong University of Science and Technology, furthering his contributions to medical education and research.

Research Interests

Liaoā€™s research focuses on biomaterials, regenerative medicine, and targeted drug delivery. He is particularly interested in 3D-bioprinted hydrogels for wound healing and the application of magnetic hydrogel microspheres in advanced drug delivery. His work also explores the diagnostic and prognostic markers for colorectal cancer and novel therapeutic strategies for inflammatory bowel diseases. His projects, funded by prestigious institutions, integrate microfluidic technology, exosome-loaded curcumin chitosan, and smart hydrogels to address medical challenges in tissue regeneration and cancer treatment.

Awards and Honors

Liao has been a key participant and principal investigator in several high-impact research projects funded by the National Natural Science Foundation of China, the National Research Foundation of Korea, and various provincial agencies. His research has resulted in multiple first-author and corresponding-author publications in leading journals like International Journal of Biological Macromolecules and Materials Today Bio. While he has not received formal academic awards, his contributions to biomaterial research and regenerative medicine have gained significant recognition in the scientific community.

Publications Top Noted

  • Title: Advances in 3D printing combined with tissue engineering for nerve regeneration and repair
    Authors: Liao, W., Shi, Y., Li, Z., Yin, X.
    Year: 2025
    Citation Count: 0
  • Title: Advanced biomaterials for diabetes healthcare and complication therapy: A review
    Authors: Wang, G., Liao, W., Han, F., Shi, Y., Hu, Z.
    Year: 2024
    Citation Count: 0
  • Title: Advances of biological macromolecules hemostatic materials: A review
    Authors: Zhang, M., Han, F., Duan, X., Cui, Q., Liao, W.
    Year: 2024
    Citation Count: 2
  • Title: Natural polyphenols for drug delivery and tissue engineering construction: A review
    Authors: Liu, Y., Shi, Y., Zhang, M., Liao, W., Duan, X.
    Year: 2024
    Citation Count: 14
  • Title: Biomaterials for inflammatory bowel disease: treatment, diagnosis and organoids
    Authors: Wang, J., Shi, Y., Mao, B., Hu, Z., Liao, W.
    Year: 2024
    Citation Count: 5
  • Title: Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications
    Authors: Ding, J., Ding, X., Liao, W., Lu, Z.
    Year: 2024
    Citation Count: 5
  • Title: Revolutionizing digestive system tumor organoids research: Exploring the potential of tumor organoids
    Authors: Xiu, Z., Yang, Q., Xie, F., He, W., Liao, W.
    Year: 2024
    Citation Count: 1
  • Title: 3D-bioprinted double-crosslinked angiogenic alginate/chondroitin sulfate patch for diabetic wound healing
    Authors: Liao, W., Duan, X., Xie, F., Wang, X., Hu, Z.
    Year: 2023
    Citation Count: 21
  • Title: The Association Between Serum Endocan Level and Short-Term Prognosis of Patients With Acute Ischemic Stroke
    Authors: Han, F., Liao, W., Duan, X., Shi, Y., Hu, Z.
    Year: 2022
    Citation Count: 6
  • Title: 3D-bioprinted peptide coupling patches for wound healing
    Authors: Guan, G., Lv, Q., Liu, S., Zhou, C., Liao, W.
    Year: 2022
    Citation Count: 53